[Asia Economy Reporter Kwon Jaehee]
▲ SK Hynix = Will hold an investor and media briefing (IR) on the 26th regarding the business performance for the third quarter of 2022.
▲ Dynamic Design = The Korea Exchange KOSPI Market Division requested a disclosure inquiry regarding significant market fluctuations for Dynamic Design. The deadline for response is by 6 PM on the 7th.
▲ Hyundai Mobis = Announced on the 6th that it will hold an analyst briefing (IR) on the 7th.
▲ SK Bioscience = Announced on the 6th that it has changed its application to the Ministry of Food and Drug Safety to include the booster shot indication for Novavax's COVID-19 vaccine 'NVX-CoV2373'.
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- Trump Team Tosses All 'Items Received in China' into Trash Before Boarding Private Jet
- 'Monster Heatwaves' Soaring to 48 Degrees Issue Chilling Warning: "Birds Are Defenseless, Their Fate Unknown" [Experimental Note]
- "Target Price Set at 970,000 Won"... Top Investors Already Watching, Only an 'Uptrend' Remains [Weekend Money]
▲ Aprogen = Regarding the report 'Aprogen pursuing acquisition of FDA-approved plant in the US,' stated on the 6th that "To respond to the US government's 'Made in America' policy and to secure competitiveness in the US biopharmaceutical market, various strategic options including the acquisition of an FDA-approved plant in the US are being reviewed, but nothing has been specifically decided yet."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
